MRUS
Merus BV
NASDAQ: MRUS · HEALTHCARE · BIOTECHNOLOGY
$90.00
+0.00% today
Updated 2025-12-30
Market cap
$6.83B
P/E ratio
—
P/S ratio
120.59x
EPS (TTM)
$-5.28
Dividend yield
—
52W range
$33 – $97
Volume
1.3M
Merus BV (MRUS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $10.62M | $17.16M | $4.30M | $38.81M | $76.05M | $236.11M | $249.96M | $263.38M | $231.22M | $456.60M | $376.54M | $455.49M | $785.13M |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $9.09M | $15.85M | $3.27M | $37.74M | $74.80M | $225.70M | $223.79M | $247.37M | $217.99M | $424.18M | $306.44M | $368.81M | $569.07M |
| Total liabilities | $3.32M | $6.58M | $8.63M | $7.86M | $40.26M | $178.65M | $144.87M | $132.08M | $128.95M | $140.40M | $129.49M | $99.15M | $134.77M |
| Current liabilities | $1.98M | $5.44M | $7.09M | $6.91M | $8.15M | $22.46M | $33.14M | $36.79M | $46.75M | $71.90M | $78.93M | $69.09M | $87.08M |
| Long-term debt | — | $819000.00 | $789000.00 | $525655.00 | $335493.00 | $0.00 | $0.00 | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-18.70M | $-32.46M | $-49.57M | $-69.30M | $-112.84M | $-200.93M | $-259.45M | $-314.60M | $-400.11M | $-466.93M | $-598.12M | $-753.06M | $-968.39M |
| Accounts receivable | $1.27M | $1.02M | $677318.00 | $10933.00 | $2.48M | $3.78M | $4.86M | $2.65M | $1.75M | $6.67M | $4.70M | $3.98M | $4.71M |
| Inventory | — | $1.00 | $2.00 | $0.00 | $12.46M | $1.00 | $-3.18M | $1.00 | $7.43M | $4.91M | $9.31M | $1.00 | — |
| Goodwill | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |